Company (Symbol) | Offer Date | Number Shares/ Units (M)* | Price Per Share/ Unit | Gross (M) | Net (M) | Shares Out (M) | Post Offering Market Cap (M)@ | Lead Under-writer** | Other Under-Writers |
Antigenics LLC (AGEN) | 2/3 | 4.035S | $18 | $72.50 | $66.50 | 24.7 | $444.60 | USBPG | RS |
Diversa Corp. (DVSA) | 2/14 | 8.34S | $24 | $200.10 | $184.90 | 34.1 | $818.40 | BSC | CHQ, DBAB |
Sequenom Inc. (SQNM) | 2/1 | 6.04S | $26 | $157 | $144.70 | 23.6 | $613.60 | WDR | DBAB, CHQ |
Aclara Biosciences Inc. (ACLA) | 3/20 | 10.35S | $21 | $217.40 | $201.10 | 32.5 | $682.50 | DBAB, WDR | USBPG |
Allos Therapeutics Inc. (ALTH) | 3/28 | 5S | $18 | $90 | $82.70 | 22.8 | $410.40 | SGC | PVHG USBPJ |
Arius Research Inc. (Canada; CDNX:YAR) | 3/8 | 1U | C$5 (US$3.43) | C$5 (US$3.43) | C$4.7E (US$3.3) | 2 | $6.86 | TKC | N/A |
InterMune Pharmaceuticals Inc. (ITMN) | 3/24 | 6.25S | $20 | $125 | $115.20 | 20.9 | $418 | WDR | CHQ, PVHG |
IntraBiotics Pharmaceuticals Inc. (IBPI) | 3/27 | 7.5S | $15 | $112.50 | $103.60 | 28.6 | $429 | DBAB | WDR, SGC, AHH |
Luminex Corp. (LMNX) | 3/30 | 4.5S | $17 | $76.50 | $70 | 26.7 | $453.90 | WDR | LB, DRW |
OraPharma Inc. (OPHM) | 3/9 | 4S | $18 | $72 | $66.30 | 12.6 | $226.80 | RS | USBPJ, GKMC |
Profile Therapeutics plc (UK; LSE: PTP) | 3/31 | 14.7S | #1.70 (US$2.71) | #25 (US$39.9) | #23.2 (US$37.0) | 49.1 | $133.10 | NI | N/A |
Actelion AG (Switzerland; SWX:ATLN) | 4/6 | 9S | CHF260 (US$155.21) | CHF234 (US$139.7) | N/A | 4.6 | $713.97 | CSFBC | N/A |
Exelixis Pharmaceuticals Inc. (EXEL) | 4/10 | 10.465S | $13 | $136 | $125.10 | 44 | $572 | GS | CSFBC, SGC |
Lexicon Genetics Inc. (LEXG) | 4/7 | 10S | $22 | $220 | $203.60 | 47.5 | $1,045 | JPM, CSFB | CIBC, PZC |
November AG (Germany; Neuer Markt:NBX) | 4/10 | 2S | EUR17 (US$16.24) | EUR39.7 (US$37.3) | N/A | N/A | N/A | BHVB | BLG |
Packard Bioscience Co. (PBSC) | 4/19 | 12S | $9 | $108 | $98 | 60.3 | $542.70 | ML | CHQ, RWB, BAS, TWP |
Praecis Pharmaceuticals Inc. (PRCS) | 4/26 | 9.2S | $10 | $92 | $84.30 | 40 | $400 | SSB | CIBC, CSFB |
Sangamo BioSciences Inc. (SGMO) | 4/6 | 3.5S | $15 | $52.50 | $48.80 | 20.8 | $312 | LB | CHQ, INGB, WB |
Tanox Inc. (TNOX) | 4/6 | 7.5S | $28.50 | $213.80 | $197.60 | 41.5 | $1,182.80 | CIBC | RS, WDR, AHH, KBC |
Genomic Solutions Inc. (GNSL) | 5/5 | 7.66S | $8 | $61.30 | N/A | 23.4 | $187.20 | WDR | LB, DRW |
Girindus AG (Germany; Neuer Markt: GIR) | 5/6 | 2.59S | EUR 20 | EUR51.8 (US$45.6) | N/A | N/A | N/A | SOJC | HSBC, SK |
GPC Biotech AG (Germany; Neuer Markt:GPC) | 5/31 | 4.3S | EUR 24 | EUR103.2 (US$95.9) | N/A | N/A | N/A | CSFB | RS, SGC, SOJC |
Orchid BioSciences Inc. (ORCH) | 5/4 | 6.9S | $8 | $55.20 | $51.30 | 32.9 | $263.20 | CSFB | RS, SSB |
Paradigm Genetics Inc. (PDGM) | 5/5 | 6.75S | $7 | $47.25 | $44.40 | 25.7 | $179.90 | CHQ | JPM, PGE, SI |
ViroLogic Inc. (VLGC) | 5/2 | 5S | $7 | $35 | $30.90 | 19.7 | $137.90 | CIBC | INGB, PVHG |
Cepheid (CPHD) | 6/21 | 5S | $6 | $30 | $26.60 | 25.5 | $153 | WDR | PVHG, IA |
Charles River Laboratories Corp. (NYSE: CRL) | 6/23 | 14S | $16 | $224 | $205.30 | 33.8 | $540.80 | DLJ, LB | INGB, SGC USBPJ, DLJD |
Dendreon Corp. (DNDN) | 6/16 | 4.5S | $10 | $45 | $40.04 | 20.9 | $209 | PVHG | SGC, PGE |
MediGene AG (Germany; Neuer Markt:MDG) | 6/30 | 2.59S | EUR42 (US$40) | EUR108.8 (US$103.6) | N/A | 9.7 | $388 | BJV CAG | MSDW |
Modex Therapeutics Ltd. (Switzerland; SWX:MDXN) | 6/23 | 0.495S | CHF168 (US$101.62) | CHF83.2 (US$50.3) | N/A | 1.46 | $148.40 | BJV | N/A |
Neurochem Inc. (Canada; TSE:NRM) | 6/13 | 4.46S | C$8.25 (US$5.59) | C$36.8 (US$24.9) | C$301 (US$20.4) | N/A | N/A | LOM | CCC |
Applied Molecular Evolution Inc. (AMEV) | 7/26 | 5.35S | $19 | $101.60 | $94.50 | 22.8 | $433.20 | CIBC | PW SGC |
Arena Pharmaceuticals Inc. (AGNT) | 7/28 | 6S | $18 | $108 | $99.20 | 21 | $378 | INGB SGC | PVHG |
Argonaut Technologies Inc. (AGNT) | 7/24 | 4.6S | $15 | $69 | $63 | 17 | $255 | WDR | INGB SGC |
Chromos Molecular Systems Inc. (Canada; TSE:CHR) | 7/7 | 3.75S | C$8 (US$5.40) | C$30 (US$20.3) | C$27.5 (US$18.6) | 12.1 | $65.34 | YS | GMS BMO |
DeCode Genetics Inc. (Iceland; DCGN) | 7/21 | 11S | $18 | $198.70 | $182.20 | 44.4 | $799.20 | MSDW | LB |
Discovery Partners International Inc. (DPII) | 7/27 | 5S | $18 | $90 | $82.50 | 22.4 | $403.20 | CHQ, LB | WDR |
Gemini Genomics plc (UK; GMNI) | 7/25 | 6.45ADS | $14 | $96.60 | N/A | 63.3 | $886.20 | SGC | CHQ |
Genencor International Inc. (GCOR) | 7/27 | 7S | $18 | $126 | $115.70 | 58.9 | $1,060.20 | ML CSFB | CHQ, SSB |
GeneScan Europe AG (Germany; Neuer Markt:GEP) | 7/21 | 2.7S | EUR39.50 (US$36.87) | EUR106.8 (US$99.7) | N/A | N/A | N/A | BW | CE |
Illumina Inc. (ILMN) | 7/27 | 6S | $16 | $96 | $88 | 31.3 | $500.80 | GS | CHQ SGC |
Keryx Biopharmaceuticals Inc. (Israel; KERX) | 7/28 | 4.6S | $10 | $46 | $41.30 | 18.8 | $188 | RCP WPL | GRU |
Pain Therapeutics Inc. (PTIE) | 7/13 | 5S | $12 | $60 | $54.70 | 25.8 | $309.60 | TWP | CIBC TACG |
Pharmagene plc (UK; LSE: PGN) | 7/31 | 17.8S | #2.85 (US$4.29) | #37 (US$55.63) | N/A | N/A | N/A | N/A | N/A |
Transgenomic Inc. (TBIO) | 7/19 | 5.15S | $15 | $77.30 | $69.90 | 18.5 | $277.50 | CHQ | BSC DRW |
Variagenics Inc. (VGNX) | 7/21 | 5.75S | $14 | $80.50 | $75 | 23 | $322 | CSFB | CHQ SGC |
3-Dimensional Pharmaceuticals Inc. (DDDP) | 8/4 | 5.75S | $15 | $86.25 | $79.20 | 20 | $300 | BSC | CHQ USBPJ |
AtheroGenics Inc. (AGIX) | 8/9 | 6.9S | $8 | $55.20 | N/A | 23.8 | $190.40 | CHQ | RS, AHH AGES |
Compugen Ltd. (Israel; CGEN) | 8/14 | 5.75S | $10 | $57.50 | $53.50 | N/A | N/A | RS | USBPJ IA |
Deltagen Inc. (DGEN) | 8/3 | 8.025S | $15 | $120.40 | $111.10 | 29.8 | $447 | SSB | RS USBPJ |
Dyax Corp. (DYAX) | 8/15 | 4.6S | $15 | $69 | $63.10 | 18.7 | $280.50 | JPM | LB PGE |
Esperion Therapeutics Inc. (ESPR) | 8/10 | 6.9S | $9 | $62.10 | $57.80 | 24.9 | $224.10 | RS | CHQ USBPJ |
Genaissance Pharmaceuticals Inc. (GNSC) | 8/2 | 6.9S | $13 | $89.70 | $82.50 | 22.5 | $292.50 | DBAB | BSC SSB WDR |
Inspire Pharmaceuticals Inc. (ISPH) | 8/3 | 6.325S | $12 | $75.90 | $69.30 | 25.3 | $303.60 | DBAB | CHQ USBPJ |
Ista Pharmaceuticals Inc. (ISTA) | 8/22 | 3S | $10.50 | $31.50 | $28 | 14.7 | $154.35 | CIBC | PVHG TWP |
Large Scale Biology Corp. (LSBC) | 8/10 | 5.75S | $17 | $97.80 | N/A | 23.7 | $402.90 | JPM | CHQ WB |
LION Bioscience AG (Germany; LEON) | 8/10 | 5.3S | $39.68 | $210.30 | N/A | N/A | N/A | MSDW | DBAB |
The Medicines Co. (MDCO) | 8/8 | 6.9S | $16 | $110.40 | N/A | 30.2 | $483.20 | JPM | RS CIBC |
Pharsight Corp. (PHST) | 8/9 | 3S | $10 | $30 | $26.60 | 17.74 | $177.40 | DLJ | CHQ WSV |
Regeneration Technologies Inc. (RTIX) | 8/10 | 3.8S | $14 | $53.20 | $48.50 | 21.3 | $298.20 | BAS | LB SI |
Rosetta Inpharmatics Inc. (RSTA) | 8/4 | 8.28S | $14 | $115.90 | N/A | 31.02 | $434.28 | LB | LFC PVHG FCM |
Sirtex Medical Ltd. (Australia ASX:SRX) | 8/22 | N/A | N/A | A$15 (US$8.7) | N/A | N/A | N/A | KTM | N/A |
Telik Inc. (TELK) | 8/16 | 5.75S | $7 | $40.25 | N/A | 22.6 | $158.20 | LB | CHQ LMWW WDR FCM |
Versicor Inc. (VERS) | 8/3 | 5.29S | $11 | $58.20 | $53 | 22.7 | $249.70 | LB | CHQ PGE WDR FCM |
Ciphergen Biosystems (CIPH) | 9/29 | 6.3S | $16 | $101.20 | N/A | 25.9 | $414.40 | SGC | INGB WDR |
Durect Corp. (DRRX) | 9/28 | 7.7S | $12 | $92.40 | N/A | 46.5 | $558 | MSDW | CHQ CIBC |
Eden BioScience Corp. (EDEN) | 9/27 | 6.67S | $15 | $100.05 | $79.80 | 23.6 | $354 | ML | SI GKB RMI |
Genomica Corp. (GNOM) | 9/29 | 6.4S | $19 | $122.40 | $112.50 | 22.4 | $425.60 | CIBC | DRW PVHG |
Waratah Pharmaceuticals (Canada; CDNX:WAR) | 9/20 | 11.5S | C$0.85 (US$0.57) | C$9.7 (US$6.48) | N/A | 23.7 | C$20.145 (US$13.5) | YS | CCC |
Crucell NV (Netherlands; CRXL) | 10/29 | 8S (US$14.89) | EUR18 (US$119.1) | EUR144 | N/A | N/A | N/A WDR | GS | INGB |
Genesis Research and Development Corp. Ltd. (New Zealand) | 10/4* | N/A | N/A | NZ$34.2 (US$14) | N/A | N/A | N/A | N/A | N/A |
Genmab A/S (Denmark; COIS) | 10/11 | 6S | DKK260 (US$30) | EUR194 (US$168.4) | N/A | N/A | N/A | N/A | N/A |
InforMax Inc. (INMX) | 10/3 | 5S | $16 | $80 | $73.20 | 18.65 | $298.40 | BSC | USBPJ AHH |
Introgen Therapeutics Inc. (INGN) | 10/11 | 4.6S | $8 | $36.80 | $33.10 | 20.5 | $164 | SGC PVHG | PW |
IstoTis NV (Netherlands) | 10/11 | N/A | N/A | EUR73 (US$63.4) | N/A | N/A | N/A | N/A | N/A |
Kosan Biosciences Inc. (KOSN) | 10/9 | 5.75S | $14 | $80.50 | $73.60 | 23.85 | $333.90 | LB | CIBC SGC FCM |
MediChem Life Sciences Inc. (MCLS) | 10/26 | 7.4S | $7 | $51.50 | N/A | 26.4 | $184.80 | WDR | CHQ WB |
Pozen Inc. (POZN) | 10/11 | 5.75S | $15 | $86.30 | N/A | 27.15 | $407.25 | USBPJ | PVHG PGE |
Array Biopharma Inc. (ARRY) | 11/17 | 7.475S | $7.50 | $56.10 | N/A | 22.95 | $172.13 | LB, DBAB | LMWW |
Adolor Corp. (ADLR) | 11/14 | 6.9S | $15 | $103.50 | $95.60 | 27.9 | $418.50 | ML, LB | PGE |
AeroGen Inc. (AEGN) | 11/10 | 4.1S | $12 | $49.70 | $38.70 | 19.9 | $238.80 | CHQ | CIBC SGC |
ConjuChem Inc. (Canada; TSE:CJC) | 11/30 | 4.55S | C$5.50 | C$25.02 (US$16.32) | N/A | N/A | N/A | YS HSBCS | BMO |
Genetix Group plc (UK) | 11/29 | 21.4S | 150 pence | #17 (US$24.6) | N/A | N/A | N/A | WPL | N/A |
GlycoDesign Inc. (Canada; TSE:GD) | 11/30 | 2.128S | $11.75 | C$25.004 (US$16.26) | N/A | N/A | N/A | LOM | N/A |
ReNeuron Ltd. (UK) | 11/10 | N/A | N/A | #19.5 (US$28) | N/A | N/A | N/A | N/A | N/A |
Rigel Pharmaceuticals Inc. (RIGL) | 11/28 | 5.65S | $7 | $39.60 | $33.90 | 36.6 | $256.20 | MSDW | LB, RS |
GenVec Inc. (GNVC) | 12/12 | 4S | $9.50 | $38 | $34.10 | 17.9 | $170.05 | JPM | WDR, AGES |
Harvard Bioscience Inc. (HBIO) | 12/7 | 6.25S | $8 | $50 | $45 | 24.8 | $198.40 | TWP | DRW, INGB |
Nexia Biotechnologies Inc. (Canada; TSE:NXB) | 12/19 | 5S | C$8 | C$40 (US$26) | N/A | N/A | N/A | NBF | RBC, BMO, HSBCS |
Specialty Laboratories Inc. (NYSE:SP) | 12/8 | 5.75S | $16 | $92 | $83.80 | 21 | $336 | ML | WDR, USBPJ |
January ¿ December 2000 IPO TOTAL: $7,344.52M | |||||||||
Notes: * Number of shares (or units) sold in the offering includes those sold to satisfy overallotment options, in full or in part, when disclosed. Likewise, gross proceeds include revenues for the sale of shares (or units) to satisfy overallotment options, in full or in part, where applicable. ** See Underwriters’ Key below. @ Market capitalization calculated is based on the offering price. All stocks listed on Nasdaq exchage unless otherwise noted. ASX = Australian Stock Exchange; CDNX = Canadian Venture Exchange; LSE = London Stock Exchange; NYSE = New York Stock Exchange; SWX = Swiss Exchange; TSE = Toronto Stock Exchange N/A = Not disclosed, reported and/or available Foreign currency is converted to U.S. dollars based on the exchange rate at the time of the offering. |
|||||||||
Underwriters’ Key: AGES (A.G. Edwards & Sons Inc.) | KTM (KTM Capital Pty. Ltd.) LB (Lehman Brothers) LFC (Lazard Freres & Co. LLC) LMWW (Legg Mason Wood Walker) LOM (Loewen Ondaatje McCutcheon Ltd.) ML (Merrill Lynch & Co.) MSDW (Morgan Stanley, Dean Witter & Co.) NBF (National Bank Financial Inc.) PGE (Pacific Growth Equities Inc.) PVHG (Prudential Vector Healthcare Group) PW (PaineWebber Inc.) PZC (Punk Ziegel & Co.) RBC (RBC Dominion Securities Inc.) RCP (Roth Capital Partners) RMI (Ragen Mackenzie Inc.) RS (Robertson Stephens) RWB (Robert W. Baird & Co.) SGC (SG Cowen Securities Corp.) SI (Stephens Inc. SK (Stadtsparkasse Koln) SOJC (Sal. Oppenheim Jr. & Cie) SSB (Salomon Smith Barney Inc.) TACG (Tucker Anthony Cleary Gull) TKC (Thomas Kernaghan & Co.) TWP (Thomas Weisel Partners LLC) USBPJ (US Bancorp Piper Jaffray) WB (William Blair & Co.) WDR (Warburg Dillon Read LLC/UBS Warburg) WPL (WestLB Panmure Ltd.) WSV (Wit SoundView) |
||||||||